New Market Study Published: Iran Pharmaceuticals & Healthcare Report Q1 2014
Iran's pharmaceutical market is developing. Access to basic healthcare is widespread, reaching about 90% of the rural population and almost the entire urban population. The use of locally produced generic drugs is widespread, especially in the government healthcare sector. Furthermore, self-medication is common among the population, creating a strong (if not always legitimate) over-the-counter (OTC) drug market. BMI estimates that the total market was worth IRR51.8bn (US$4.2bn) in 2012, with OTC medicines accounting for around 10-15% of the market by...
View full press release